Welcome to our dedicated page for Westamerica Bancorporation SEC filings (Ticker: WABC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Scanning Westamerica Bancorporation’s disclosures often starts with one question: where do I find the exact numbers that move a regional bank’s stock? Whether you need the net interest margin buried in the Westamerica Bancorporation annual report 10-K simplified or want to confirm loan loss provisions in the latest Westamerica Bancorporation quarterly earnings report 10-Q filing, this page brings every document to one place.
Our platform delivers real-time updates from EDGAR and layers AI-powered summaries that translate banking jargon into clear insights. Stop hunting for executive trades; the Westamerica Bancorporation Form 4 insider transactions real-time feed flags each purchase or sale within minutes. Need a quick brief on a rate-sensitive disclosure? The �understanding Westamerica Bancorporation SEC documents with AI� tool highlights shifts in deposit mix, loan yields, and interest-rate risk—so you can act before the market digests the details.
Investors typically explore three areas first:
- Capital questions answered in the Westamerica Bancorporation 8-K material events explained filings.
- Compensation details outlined in the Westamerica Bancorporation proxy statement executive compensation materials.
- Management sentiment tracked through Westamerica Bancorporation insider trading Form 4 transactions.
Each section links directly to the source PDF while our AI provides concise context—ideal for comparing quarter-over-quarter performance or monitoring compliance trends. Whether you’re modeling net interest income, reviewing Westamerica Bancorporation earnings report filing analysis, or verifying Westamerica Bancorporation executive stock transactions Form 4, you’ll find the answers here—fully indexed, searchable, and explained simply.
Westamerica Bancorporation (WABC) Form 4 filing dated 07/10/2025 reports routine insider activity by John A. Thorson, the company’s Senior Vice President & Treasurer.
� On 07/09/2025 and 07/10/2025 Thorson exercised non-qualified stock options (transaction code M) with an exercise price of $49.70 per share. The two transactions covered 10 and 6,462 options, respectively, for a combined 6,472 options converted into common stock.
� Following the exercises, Thorson still holds 15,133 derivative securities (options) and reports ownership of 2,595 WABC common shares directly and 1,932.696 shares indirectly through the company ESOP.
The filing discloses no open-market sales or purchases of the underlying shares, and no additional compensation-related terms beyond the standard three-year ratable vesting schedule.
Investor takeaway: The exercised amount represents an immaterial fraction of WABC’s outstanding shares and appears to be a scheduled, compensation-driven event rather than a directional signal. No material impact on the company’s fundamentals or governance is indicated.
Westamerica Bancorporation (WABC) � Form 4 insider activity
Senior Vice President & Treasurer John A. Thorson filed a Form 4 reporting two option exercises on 7 July 2025 and 3 July 2025 at an exercise price of $49.70 per share. The transactions were coded �M,� indicating conversion of non-qualified stock options into common shares.
- Underlying shares acquired: 1,095 (2 + 1,093) common shares
- Direct common shares after transactions: 2,595
- Indirect ESOP shares: 1,932.696
- Remaining unexercised options: 21,605
The options originated from a grant dated 25 Jan 2025 and vest ratably over three years beginning one year from grant. No open-market sales were reported, implying the newly issued shares are now part of Thorson’s direct ownership. The aggregate size of the exercise is modest relative to Westamerica’s public float, so the filing is not expected to materially move the stock but may be viewed as a show of executive confidence.
UBS AG is offering $170,000 in Trigger Autocallable Contingent Yield Notes linked to the common stock of UnitedHealth Group Incorporated (UNH). The three-year notes pay a 10.12% p.a. contingent coupon each quarter only when UNH’s closing price is at or above the Coupon Barrier of $185.13 (60% of the $308.55 Initial Level). If UNH closes at or above the Initial Level on any observation date prior to maturity, the notes are automatically called and investors receive the $10 principal plus the applicable coupon.
If not called, principal is protected at maturity only when the Final Level is at or above the Downside Threshold (also $185.13). Should UNH finish below this threshold, repayment equals $10 Ă— (1 + underlying return), exposing investors to a one-for-one loss that could reach 100% of capital.
- Issue price: $10 per note (minimum purchase 100 notes).
- Estimated initial value: $9.51, reflecting underwriting discount ($0.225 per note) and hedging/issuance costs.
- Observation schedule: Quarterly dates from 6 Oct 2025 through 6 Jul 2028; maturity 10 Jul 2028.
- Credit risk: Unsubordinated, unsecured obligations of UBS AG; payments depend on UBS solvency and are not FDIC-insured.
- Liquidity: Notes will not be listed; secondary market making is at UBS’s discretion and may involve significant bid–ask spreads.
Key risk highlights include potential loss of up to 100% of principal, non-payment of coupons if UNH trades below the barrier, valuation and liquidity uncertainties, conflicts of interest in pricing and hedging, and complex U.S. tax treatment. The product may appeal to investors comfortable with single-stock volatility who seek enhanced income and can tolerate both equity downside and issuer credit exposure.